A citation-based method for searching scientific literature

Xavier Cahu, Stefan N Constantinescu. Curr Hematol Malig Rep 2015
Times Cited: 14







List of co-cited articles
36 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Somatic mutations of calreticulin in myeloproliferative neoplasms.
Thorsten Klampfl, Heinz Gisslinger, Ashot S Harutyunyan, Harini Nivarthi, Elisa Rumi, Jelena D Milosevic, Nicole C C Them, Tiina Berg, Bettina Gisslinger, Daniela Pietra,[...]. N Engl J Med 2013
35

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
J Nangalia, C E Massie, E J Baxter, F L Nice, G Gundem, D C Wedge, E Avezov, J Li, K Kollmann, D G Kent,[...]. N Engl J Med 2013
21


JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response.
Maria Kleppe, Minsuk Kwak, Priya Koppikar, Markus Riester, Matthew Keller, Lennart Bastian, Todd Hricik, Neha Bhagwat, Anna Sophia McKenney, Efthymia Papalexi,[...]. Cancer Discov 2015
195
21

Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer.
Bettina Wingelhofer, Heidi A Neubauer, Peter Valent, Xiaonan Han, Stefan N Constantinescu, Patrick T Gunning, Mathias Müller, Richard Moriggl. Leukemia 2018
115
21

Calreticulin signaling in health and disease.
Wen-An Wang, Jody Groenendyk, Marek Michalak. Int J Biochem Cell Biol 2012
132
14

STAT1 activation in association with JAK2 exon 12 mutations.
Anna L Godfrey, Edwin Chen, Charles E Massie, Yvonne Silber, Francesca Pagano, Beatriz Bellosillo, Paola Guglielmelli, Claire N Harrison, John T Reilly, Frank Stegelmann,[...]. Haematologica 2016
10
20


Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis.
Raajit Rampal, Fatima Al-Shahrour, Omar Abdel-Wahab, Jay P Patel, Jean-Philippe Brunel, Craig H Mermel, Adam J Bass, Jennifer Pretz, Jihae Ahn, Todd Hricik,[...]. Blood 2014
270
14

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms.
Gregor Hoermann, Georg Greiner, Peter Valent. Mediators Inflamm 2015
33
14

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.
Francisco Cervantes, Brigitte Dupriez, Arturo Pereira, Francesco Passamonti, John T Reilly, Enrica Morra, Alessandro M Vannucchi, Ruben A Mesa, Jean-Loup Demory, Giovanni Barosi,[...]. Blood 2009
848
14

MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives.
Hans Carl Hasselbalch, Mads Emil Bjørn. Mediators Inflamm 2015
111
14

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).
Francesco Passamonti, Francisco Cervantes, Alessandro Maria Vannucchi, Enrica Morra, Elisa Rumi, Arturo Pereira, Paola Guglielmelli, Ester Pungolino, Marianna Caramella, Margherita Maffioli,[...]. Blood 2010
618
14

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
14

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
Yana Pikman, Benjamin H Lee, Thomas Mercher, Elizabeth McDowell, Benjamin L Ebert, Maricel Gozo, Adam Cuker, Gerlinde Wernig, Sandra Moore, Ilene Galinsky,[...]. PLoS Med 2006
14

A gain-of-function mutation of JAK2 in myeloproliferative disorders.
Robert Kralovics, Francesco Passamonti, Andreas S Buser, Soon-Siong Teo, Ralph Tiedt, Jakob R Passweg, Andre Tichelli, Mario Cazzola, Radek C Skoda. N Engl J Med 2005
14

Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis.
Caroline Marty, Christian Pecquet, Harini Nivarthi, Mira El-Khoury, Ilyas Chachoua, Micheline Tulliez, Jean-Luc Villeval, Hana Raslova, Robert Kralovics, Stefan N Constantinescu,[...]. Blood 2016
182
14

Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients.
Ayalew Tefferi, Emnet A Wassie, Paola Guglielmelli, Naseema Gangat, Alem A Belachew, Terra L Lasho, Christy Finke, Rhett P Ketterling, Curtis A Hanson, Animesh Pardanani,[...]. Am J Hematol 2014
146
14

The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms.
Zhiyuan Wu, Xinju Zhang, Xiao Xu, Yuming Chen, Tingting Hu, Zhihua Kang, Shibao Li, Hua Wang, Weiwei Liu, Xiaochao Ma,[...]. J Hematol Oncol 2014
31
14

Calreticulin: non-endoplasmic reticulum functions in physiology and disease.
Leslie I Gold, Paul Eggleton, Mariya T Sweetwyne, Lauren B Van Duyn, Matthew R Greives, Sara-Megumi Naylor, Marek Michalak, Joanne E Murphy-Ullrich. FASEB J 2010
278
14

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.
Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, Hans Michael Kvasnicka, Alessandro M Vannucchi, Paola Guglielmelli, Attilio Orazi, Ayalew Tefferi. Blood Cancer J 2018
254
14

Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis.
Ilaria Ceglia, Amylou C Dueck, Francesca Masiello, Fabrizio Martelli, Wu He, Giulia Federici, Emanuel F Petricoin, Ann Zeuner, Camelia Iancu-Rubin, Rona Weinberg,[...]. Exp Hematol 2016
32
14

Myelofibrosis: clinicopathologic features, prognosis, and management.
Jennifer M O'Sullivan, Claire N Harrison. Clin Adv Hematol Oncol 2018
25
14

Inhibition of STAT5: a therapeutic option in BCR-ABL1-driven leukemia.
Angelika Berger, Veronika Sexl, Peter Valent, Richard Moriggl. Oncotarget 2014
32
14

Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth.
Florian M Corvinus, Carina Orth, Richard Moriggl, Svetlana A Tsareva, Stefan Wagner, Edith B Pfitzner, Daniela Baus, Roland Kaufmann, Lukas A Huber, Kurt Zatloukal,[...]. Neoplasia 2005
301
14

High-throughput thermofluor-based assays for inhibitor screening of STAT SH2 domains.
Elvin D de Araujo, Pimyupa Manaswiyoungkul, Johan Israelian, Jisung Park, Karen Yuen, Shiva Farhangi, Angelika Berger-Becvar, Lubna Abu-Jazar, Patrick T Gunning. J Pharm Biomed Anal 2017
13
15

Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma.
Nicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, Huan Chang Liang, Michaela Schlederer, Simone Roos, Lawren C Wu, Ingrid Simonitsch-Klupp, Andrea Alvarez-Hernandez, Christoph Kornauth,[...]. Leukemia 2019
29
14


TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.
Takaomi Sanda, Jeffrey W Tyner, Alejandro Gutierrez, Vu N Ngo, Jason Glover, Bill H Chang, Arla Yost, Wenxue Ma, Angela G Fleischman, Wenjun Zhou,[...]. Cancer Discov 2013
104
14

STAT1 acts as a tumor promoter for leukemia development.
Boris Kovacic, Dagmar Stoiber, Richard Moriggl, Eva Weisz, René G Ott, Rita Kreibich, David E Levy, Hartmut Beug, Michael Freissmuth, Veronika Sexl. Cancer Cell 2006
115
14

The STATs of cancer--new molecular targets come of age.
Hua Yu, Richard Jove. Nat Rev Cancer 2004
14

Stat3 as an oncogene.
J F Bromberg, M H Wrzeszczynska, G Devgan, Y Zhao, R G Pestell, C Albanese, J E Darnell. Cell 1999
14

Structural and functional consequences of the STAT5BN642H driver mutation.
Elvin D de Araujo, Fettah Erdogan, Heidi A Neubauer, Deniz Meneksedag-Erol, Pimyupa Manaswiyoungkul, Mohammad S Eram, Hyuk-Soo Seo, Abdul K Qadree, Johan Israelian, Anna Orlova,[...]. Nat Commun 2019
32
14


STAT5BN642H is a driver mutation for T cell neoplasia.
Ha Thi Thanh Pham, Barbara Maurer, Michaela Prchal-Murphy, Reinhard Grausenburger, Eva Grundschober, Tahereh Javaheri, Harini Nivarthi, Auke Boersma, Thomas Kolbe, Mohamed Elabd,[...]. J Clin Invest 2018
45
14

Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity.
Tiancen Hu, Jennifer E Yeh, Luca Pinello, Jaison Jacob, Srinivas Chakravarthy, Guo-Cheng Yuan, Rajiv Chopra, David A Frank. Mol Cell Biol 2015
34
14


Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia Vera.
Miguel Gallardo, Santiago Barrio, Marisol Fernandez, Alberto Paradela, Alicia Arenas, Oscar Toldos, Rosa Ayala, Enriqueta Albizua, Ana Jimenez, Santiago Redondo,[...]. Mol Cancer 2013
16
7

Cell death.
Richard S Hotchkiss, Andreas Strasser, Jonathan E McDunn, Paul E Swanson. N Engl J Med 2009
782
7


Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor.
Christian Pecquet, Judith Staerk, Ronan Chaligné, Valerie Goss, Kimberly A Lee, Xiaowu Zhang, John Rush, Joanne Van Hees, Hélène A Poirel, Jean-Marie Scheiff,[...]. Blood 2010
58
7

Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.
Peter E Czabotar, Guillaume Lessene, Andreas Strasser, Jerry M Adams. Nat Rev Mol Cell Biol 2014
7



Therapeutic potential of JAK2 inhibitors.
Srdan Verstovsek. Hematology Am Soc Hematol Educ Program 2009
67
7

Many players in BCL-2 family affairs.
Tudor Moldoveanu, Ariele Viacava Follis, Richard W Kriwacki, Douglas R Green. Trends Biochem Sci 2014
287
7

Anti-apoptotic pathways in bone marrow and megakaryocytes in myeloproliferative neoplasia.
Suzanne M Koopmans, Harry C Schouten, Arienne M W van Marion. Pathobiology 2014
10
10

Apoptotic detection methods--from morphology to gene.
Yoshinori Otsuki, Zhonglian Li, Masa-Aki Shibata. Prog Histochem Cytochem 2003
105
7

Cellular mechanisms controlling caspase activation and function.
Amanda B Parrish, Christopher D Freel, Sally Kornbluth. Cold Spring Harb Perspect Biol 2013
348
7

A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.
Guido Finazzi, Alessandro M Vannucchi, Vincenzo Martinelli, Marco Ruggeri, Francesco Nobile, Giorgina Specchia, Enrico Maria Pogliani, Odoardo Maria Olimpieri, Giuseppe Fioritoni, Caterina Musolino,[...]. Br J Haematol 2013
90
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.